| Aspermont Limited (ASP) ORDINARY FULLY PAID |
Communication Services |
$15 |
Aspermont FY24 Results Presentation
|
28 Nov 2024 8:41AM |
$0.006 |
$0.006 |
fallen by
0%
|
|
| Atomos Limited (AMS) ORDINARY FULLY PAID |
Consumer Discretionary |
$18 |
AGM Trading Update
|
28 Nov 2024 8:40AM |
$0.018 |
$0.015 |
fallen by
16.67%
|
|
AMS - Price-sensitive ASX Announcement
Full Release
Key Points
- New Products Shipping - Ninja Phone and SunDragon shipped in November.
- Product Development – Shinobi II success exceeded expectations.
- Further reduction in operating costs through restructuring.
- Direct to Consumer (D2C) website launched targeting social content creators.
- Core products performed well in Q1 but faced pricing pressure in Q2.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dalrymple Bay Infrastructure Limited (DBI) FULLY PAID ORDINARY/NOTES STAPLED SECURITIES |
Industrials |
$1,705 |
Dividend/Distribution - DBI
|
28 Nov 2024 8:40AM |
$3.350 |
$3.440 |
risen by
2.69%
|
|
| Dalrymple Bay Infrastructure Limited (DBI) FULLY PAID ORDINARY/NOTES STAPLED SECURITIES |
Industrials |
$1,705 |
Q3-24 Distribution
|
28 Nov 2024 8:38AM |
$3.350 |
$3.440 |
risen by
2.69%
|
|
| Infocus Group Holdings Limited (IFG) ORDINARY FULLY PAID |
Information Technology |
$5 |
Application for quotation of securities - IFG
|
28 Nov 2024 8:37AM |
$0.042 |
$0.031 |
fallen by
26.19%
|
|
| Australian Foundation Investment Company Limited (AFI) ORDINARY FULLY PAID |
Financials |
$9,475 |
Update - Notification of buy-back - AFI
|
28 Nov 2024 8:37AM |
$7.520 |
$7.550 |
risen by
0.40%
|
|
| White Energy Company Limited (WEC) ORDINARY FULLY PAID |
Energy |
$10 |
2024 AGM Chairmans Address and CEOs Address
|
28 Nov 2024 8:37AM |
$0.048 |
$0.048 |
fallen by
0%
|
|
| Far East Gold Ltd (FEG) ORDINARY FULLY PAID |
Materials |
$53 |
FIRB Approval Received for Strategic Investor Funding
|
28 Nov 2024 8:37AM |
$0.165 |
$0.165 |
fallen by
0%
|
|
FEG - Price-sensitive ASX Announcement
Full Release
Key Points
- FIRB approval received for strategic investor funding.
- Approval pertains to Tranche 2 and Tranche 3 funding.
- Share issuance will follow upon receipt of funds.
- CEO Shane Menere described the approval as a significant milestone.
- Partnership with a successful Chinese precious metals producer validates FEG's asset potential.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aspermont Limited (ASP) ORDINARY FULLY PAID |
Communication Services |
$15 |
Annual Report to shareholders
|
28 Nov 2024 8:34AM |
$0.006 |
$0.006 |
fallen by
0%
|
|
| Healius Limited (HLS) ORDINARY FULLY PAID |
Health Care |
$1,002 |
Change of Director's Interest Notice
|
28 Nov 2024 8:33AM |
$1.405 |
$1.380 |
fallen by
1.78%
|
|
| Paradigm Biopharmaceuticals Limited (PAR) ORDINARY FULLY PAID |
Health Care |
$180 |
Paradigm to Proceed with Phase 3 Knee OA Trial
|
28 Nov 2024 8:33AM |
$0.575 |
$0.515 |
fallen by
10.43%
|
|
PAR - Price-sensitive ASX Announcement
Full Release
Key Points
- Successful conclusion of 30-day FDA review period enabling Paradigm to proceed with the pivotal phase 3 clinical trial (PARA_OA_012)
- Optimal 2mg/kg twice weekly iPPS dosing regimen reflecting multiple successful phase 2 trials
- Preparations for the pivotal phase 3 clinical trial well advanced
- On track to commence patient enrolment in Q1 CY2025
- Primary endpoint of the trial is a change from baseline in pain
- Key secondary endpoints include pain and functional assessments at multiple timepoints
- FDA's feedback has been fully integrated into trial design and endpoints
- Trial designed to enroll approximately 466 participants in a 1:1 randomisation design
- Interim analysis planned when 50% of subjects reach the Day 112 follow-up
- Represents a major milestone for the Company enabling engagement with key potential partners
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Infocus Group Holdings Limited (IFG) ORDINARY FULLY PAID |
Information Technology |
$5 |
Application for quotation of securities - IFG
|
28 Nov 2024 8:33AM |
$0.042 |
$0.031 |
fallen by
26.19%
|
|
| Aspermont Limited (ASP) ORDINARY FULLY PAID |
Communication Services |
$15 |
Appendix 4E Summary
|
28 Nov 2024 8:30AM |
$0.006 |
$0.006 |
fallen by
0%
|
|
| Cadence Capital Limited (CDM) ORDINARY FULLY PAID |
Financials |
$210 |
Update - Notification of buy-back - CDM
|
28 Nov 2024 8:30AM |
$0.700 |
$0.700 |
fallen by
0%
|
|
| Insurance Australia Group Limited (IAG) ORDINARY FULLY PAID |
Financials |
$20,184 |
IAG and RACQ enter long-term strategic alliance
|
28 Nov 2024 8:29AM |
$8.180 |
$8.530 |
risen by
4.28%
|
|
IAG - Price-sensitive ASX Announcement
Full Release
Key Points
- IAG and RACQ announce a 25-year exclusive strategic alliance.
- IAG will acquire 90% of RACQ's existing insurance underwriting business.
- Total consideration for the deal is $855 million.
- The alliance aims to provide RACQ members with better insurance products.
- Transaction expected to be EPS accretive in the first full year.
- IAG will maintain its existing brands in Queensland.
- The new partnership will utilize IAG's technology and customer service expertise.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Telix Pharmaceuticals Limited (TLX) ORDINARY FULLY PAID |
Health Care |
$8,281 |
Notification regarding unquoted securities - TLX
|
28 Nov 2024 8:29AM |
$23.360 |
$24.740 |
risen by
5.91%
|
|
| Wildcat Resources Limited (WC8) ORDINARY FULLY PAID |
Materials |
$297 |
WILDCAT DELIVERS MRE OF 74.1MT @ 1.0% Li2O
|
28 Nov 2024 8:28AM |
$0.250 |
$0.240 |
fallen by
4%
|
|
WC8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Wildcat Resources Limited announces a maiden Mineral Resource Estimate for Tabba Tabba.
- The MRE totals 74.1 million tonnes at 1.0% Li2O.
- Resource classification is 94% indicated and 6% inferred.
- Tabba Tabba is positioned 80 km from Port Hedland, enhancing its development potential.
- The project has significant development advantages including granted Mining Leases.
- Wildcat Resources is recognized for rapid resource delivery in a short timeframe.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Artemis Resources Limited (ARV) ORDINARY FULLY PAID |
Materials |
$19 |
High Grade Gold and Copper Assays at Thorpe Prospect
|
28 Nov 2024 8:28AM |
$0.008 |
$0.010 |
risen by
25%
|
|
ARV - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade gold and copper assays at Thorpe Prospect.
- Rock chip sampling returned grades of up to 45.8 g/t gold and 10.3% copper.
- Exploration aimed at mapping mineralized veins and increasing drilling targets.
- Mineralisation associated with quartz-iron oxide veining.
- Plans for drilling key targets early in 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| SDI Limited (SDI) ORDINARY FULLY PAID |
Health Care |
$131 |
2024 CEO AGM Presentation
|
28 Nov 2024 8:28AM |
$1.080 |
$1.105 |
risen by
2.31%
|
|
SDI - Price-sensitive ASX Announcement
Full Release
Key Points
- Record revenue of A$111.2 million for FY24.
- EBITDA increased by 35.5% to A$21.9 million.
- Secured European registration for new Aesthetic product Stela.
- Project Montrose is set to improve production efficiency with a budget of A$56 million.
- Established an ESG roadmap to enhance sustainability and social responsibility.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Telix Pharmaceuticals Limited (TLX) ORDINARY FULLY PAID |
Health Care |
$8,281 |
Application for quotation of securities - TLX
|
28 Nov 2024 8:27AM |
$23.360 |
$24.740 |
risen by
5.91%
|
|
| AVJennings Limited (AVJ) ORDINARY FULLY PAID |
Consumer Discretionary |
$346 |
All Cash Proposal from AVID to Acquire AVJennings
|
28 Nov 2024 8:25AM |
$0.330 |
$0.620 |
risen by
87.88%
|
|
AVJ - Price-sensitive ASX Announcement
Full Release
Key Points
- AVJennings received an unsolicited proposal from AVID to acquire shares for $0.671 each.
- The offer represents a 103% premium over the closing price of AVJ shares prior to the announcement.
- The proposal is subject to due diligence, board approval, and regulatory approvals.
- AVJennings intends to recommend the proposal to shareholders if terms are finalized.
- AVID's proposal includes the possibility of a special dividend for shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| US Masters Residential Property Fund (URF) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
$254 |
Update - Notification of buy-back - URF
|
28 Nov 2024 8:25AM |
$0.360 |
$0.360 |
fallen by
0%
|
|
| SDI Limited (SDI) ORDINARY FULLY PAID |
Health Care |
$131 |
Chair's Address to Shareholders
|
28 Nov 2024 8:25AM |
$1.080 |
$1.105 |
risen by
2.31%
|
|
SDI - Price-sensitive ASX Announcement
Full Release
Key Points
- 2024 financial year has been a challenging one but resulted in record after-tax profit of $10.4 million.
- Sales grew to a record $111.2 million led by aesthetic products and strong growth in the European market.
- Continued decline in sales of Amalgam products, offset by the introduction of the new product Stela.
- Product margin increased to 62.1% driven by logistic cost normalization and product mix.
- New European Union Medical Device Regulation has been a major focus, with successful product registration.
- New 24,000sqm property in Montrose to enhance production and warehousing efficiency.
- Future goals include transitioning amalgam customers to Stela and ensuring compliance with new regulations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Argo Investments Limited (ARG) ORDINARY FULLY PAID |
Financials |
$6,984 |
Update - Notification of buy-back - ARG
|
28 Nov 2024 8:24AM |
$9.080 |
$9.140 |
risen by
0.66%
|
|
| Helia Group Limited (HLI) ORDINARY FULLY PAID |
Financials |
$1,238 |
Update - Notification of buy-back - HLI
|
28 Nov 2024 8:24AM |
$4.410 |
$4.470 |
risen by
1.36%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
